Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Welltower (HCN) Stock Price
Press coverage about Welltower (NYSE:HCN) has been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Welltower earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned news stories about the real estate investment trust an impact score of 46.6342159005017 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the news articles that may have effected Accern’s rankings:
- Short Term Technical Analysis: Welltower Inc. (HCN), Edwards Lifesciences Corporation (EW) – Market Movers (financialqz.com)
- Welltower Vs. Ventas: Battle Of The REITs – Seeking Alpha (seekingalpha.com)
- Most Shocking Stock Movements: Welltower Inc. (HCN), Tenet Healthcare Corp. (THC) – Market Movers (financialqz.com)
- Tax Reform Could Strike Blow to Nonprofit CCRCs (seniorhousingnews.com)
- Drilling Down Into – TechnipFMC plc, (NYSE: FTI), Welltower Inc., (NYSE: HCN) – Stocks In The News (press release) (tradingnewsnow.com)
A number of research analysts have weighed in on HCN shares. Royal Bank Of Canada reissued a “hold” rating and set a $74.00 target price on shares of Welltower in a research report on Wednesday, September 6th. Bank of America lowered shares of Welltower to a “neutral” rating and cut their target price for the stock from $78.00 to $77.00 in a research report on Friday, September 22nd. Capital One Financial started coverage on shares of Welltower in a research report on Monday, September 25th. They set an “equal weight” rating and a $74.00 target price for the company. UBS cut their target price on shares of Welltower from $71.00 to $69.00 and set a “neutral” rating for the company in a research report on Monday, October 2nd. Finally, Jefferies Group reissued a “hold” rating and set a $72.00 target price on shares of Welltower in a research report on Tuesday, October 3rd. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $72.71.
Welltower (NYSE:HCN) last issued its quarterly earnings data on Tuesday, November 7th. The real estate investment trust reported $1.08 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.03. The firm had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Welltower had a net margin of 22.67% and a return on equity of 7.45%. The company’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.16 earnings per share. equities analysts predict that Welltower will post 4.24 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Monday, November 20th. Stockholders of record on Tuesday, November 7th were paid a dividend of $0.87 per share. The ex-dividend date was Monday, November 6th. This represents a $3.48 annualized dividend and a dividend yield of 5.25%. Welltower’s dividend payout ratio (DPR) is currently 140.32%.
In related news, Director Gary Whitelaw purchased 1,420 shares of the firm’s stock in a transaction dated Tuesday, November 21st. The shares were acquired at an average cost of $68.39 per share, with a total value of $97,113.80. Following the completion of the purchase, the director now directly owns 1,420 shares of the company’s stock, valued at $97,113.80. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.19% of the stock is owned by corporate insiders.
WARNING: This article was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/12/09/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-welltower-hcn-stock-price.html.
Welltower Inc invests with seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. The Company invests in seniors housing and healthcare real estate. It operates in three segments: triple-net, seniors housing operating and outpatient medical. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities, and outpatient medical properties.
Receive News & Stock Ratings for Welltower Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower Inc. and related stocks with our FREE daily email newsletter.